Enalees’ new proteomics development and production laboratory within SEM facilities was inaugurated on 6 April 2023. Enalees conceives, manufactures and markets next-generation (LAMP technology), rapid molecular diagnostic tests for the veterinary sector. Its new laboratory and the resulting capacities extension is part of its development plan and the company received a €500,000 subvention for it in October 2022 from the Île-de-France Administrative Region as part of the France 2030 Investments for the Future program. Accompanying biocluster businesses at each phase of their development is one of Genopole’s pillars, and well illustrated by this advancement for Enalees.
